Stay updated on Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial
Sign up to get notified when there's something new on the Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial page.

Latest updates to the Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial page
- Check3 days agoChange DetectedThe page's revision label has been updated from v3.6.3 to v3.6.4, reflecting a newer version of the study details page.SummaryDifference0.1%

- Check10 days agoChange DetectedThere are no additions or deletions reported in the supplied changes data for this page.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new site revision (v3.6.3) has been added to the revision history, replacing v3.6.2, indicating a recent system update. This update does not change the study text, eligibility criteria, or results on this page.SummaryDifference0.0%

- Check31 days agoChange DetectedAdded a link to the Study Protocol and Statistical Analysis Plan PDF and related documentation on the study page, expanding access to official materials for the trial.SummaryDifference66%

- Check45 days agoChange DetectedAdded a recruitment-closure notice and new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study); updated labeling from 'Intervention / Treatment' to 'Intervention/Treatment' and revised the page version to v3.6.0.SummaryDifference0.4%

- Check52 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5. This reflects a minor document version update rather than a substantive change to study information.SummaryDifference0.0%

Stay in the know with updates to Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial page.